Healthcare
VC backers divest GlycoVaxyn to GSK
Deal values biopharmaceutical company at $212m
VC-backed Bone Therapeutics raises €32m in IPO
Dual listing gives company a market cap of €104.8m
Smedvig leads $13.5m investment in TrialReach
Amadeus and Octopus also take part in round
Thuja et al. invest €1.8m in FabPulous
Thuja invested via its Thuja Capital Healthcare Fund
SHS backs AOT
Growing market for robot-guided surgical systems prompts investment
Thuja et al. invest €2.4m in Therasolve
VC was joined by business angels in the round
Kernel et al. invest €2m in Hibergene
Company will use the funds to commercialise its first two products
BMT backs Oncgnostics series-A
HTGF initially provided seed funding in 2012
Seventure's AAA plans flotation
Company received €41m in funding last year
VC-backed Bone Therapeutics to list
Company could raise up to €28.8m at the top end of the indicative price range
Atlas Genetics raises $20m
Company will launch first testing product later this year
VC-backed Ascendis raises $108m in IPO
Listing priced at $18 per share
Industrifonden invests SEK 10m in AMRA
Second investment in company for Industrifonden
Capricorn et al. invest €1.3m in Feops
Funding will be used to launch company's first product in Europe and US
Fund in focus: Gilde Healthcare closes GHS II on €100m
Managing partner Jasper van Gorp shares details with unquote"
Seroba et al. invest £18m in Veryan
Company plans on commercialising its product later this year
Sunstone et al in €20m series-B for Orphazyme
Total funding for Orphazyme reaches тЌ34m with latest round
Gimv's Almaviva bolts on Paris hospital
Bolt-on increases Almaviva's 2014 revenues to €130m
SV et al. sell Convergence for $675m
VCs invested in the company in 2010
Thuja et al. invest in Hemics
Company plans to commercialise HandScan product
3i-backed OneMed acquires Bosman Medical Devices
Acquisition will support OneMed's international growth and expand product range
Seventure backs MaaT
Firm commits to invest further €1m based on milestones
Fountain Healthcare launches second fund
Fund will invest primarly in European healthcare
Miracor raises €4.5m series-B extension
€7m series-B took place in September 2011